Jump to ContentJump to Main Navigation
Show Summary Details
More options …

Open Medicine

formerly Central European Journal of Medicine

Editor-in-Chief: Darzynkiewicz, Zbigniew


IMPACT FACTOR 2018: 1.221

CiteScore 2018: 1.01

SCImago Journal Rank (SJR) 2018: 0.329
Source Normalized Impact per Paper (SNIP) 2018: 0.479

ICV 2017: 152.94

Open Access
Online
ISSN
2391-5463
See all formats and pricing
More options …
Volume 14, Issue 1

Issues

Volume 10 (2015)

Correlation between iPTH levels on the first postoperative day after total thyroidectomy and permanent hypoparathyroidism: our experience

Gian Luigi Canu
  • Corresponding author
  • Department of Surgical Sciences, University of Cagliari, “Policlinico Universitario Duilio Casula”, 09042, Monserrato (CA), Italy
  • Email
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ Fabio Medas
  • Department of Surgical Sciences, University of Cagliari, “Policlinico Universitario Duilio Casula”, 09042, Monserrato (CA), Italy
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ Alessandro Longheu
  • Department of Surgical Sciences, University of Cagliari, “Policlinico Universitario Duilio Casula”, 09042, Monserrato (CA), Italy
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ Francesco Boi
  • Department of Medical Sciences, University of Cagliari, Endocrinology Unit, “Policlinico Universitario Duilio Casula”, 09042, Monserrato (CA), Italy
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ Giovanni Docimo
  • Department of General Surgery, General and Endocrine Surgical Unit, Second University of Naples, 80131, Naples, Italy
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ Enrico Erdas
  • Department of Surgical Sciences, University of Cagliari, “Policlinico Universitario Duilio Casula”, 09042, Monserrato (CA), Italy
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
/ Pietro Giorgio Calò
  • Department of Surgical Sciences, University of Cagliari, “Policlinico Universitario Duilio Casula”, 09042, Monserrato (CA), Italy
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
Published Online: 2019-06-07 | DOI: https://doi.org/10.1515/med-2019-0047

Abstract

Permanent hypoparathyroidism is the most common long-term complication after thyroidectomy. We evaluated whether iPTH concentrations on the first postoperative day may be a good predictor of this complication.

Patients undergoing thyroidectomy in our Unit between January 2017 and February 2018 who developed postsurgical hypoparathyroidism were analysed. According to iPTH values on the first postoperative day and on the basis of the detection threshold of the iPTH test used, patients were divided into 2 groups: Group A (iPTH < 6.3 pg/mL, undetectable), Group B (iPTH ≥ 6.3 pg/mL).

Seventy-five patients were included in this study: 64 in Group A and 11 in Group B. Permanent hypoparathyroidism occurred in 14 (21.88%) patients in Group A, while none developed this complication in Group B. When iPTH was < 6.3 pg/mL, the sensitivity for the prediction of permanent hypoparathyroidism was 100%, the specificity was 18.03%, the positive predictive value was 21.88% and the negative predictive value was 100%.

No patient with iPTH ≥ 6.3 pg/mL on the first postoperative day developed permanent hypoparathyroidism. On the other hand, iPTH concentrations < 6.3 pg/mL have not proved to be a strong predictor of this condition. However, this cut-off value can be useful to identify patients at risk of developing this complication.

Keywords: Permanent hypoparathyroidism; Total thyroidectomy; Intact parathyroid hormone; Undetectable iPTH

1 Introduction

Total thyroidectomy (TT) is the most widely surgical procedure performed in endocrine surgery, for both benign and malignant thyroid diseases.

Hypoparathyroidism (HPP) is a common complication after TT [1, 2, 3, 4, 5, 6, 7, 8, 9]. This condition is characterized by decreased values of circulating parathyroid hormone leading to hypocalcemia and slightly higher phosphate levels.

Hypocalcemia can cause symptoms ranging from numbness of the face and hands to tetany, convulsions and suffocation (caused by laryngeal and diaphragmatic spasms). Moreover, manifestations of chronic hypocalcemia include some severe conditions, such as nephrocalcinosis, kidney stones, chronic kidney disease, myocardial dysfunction, basal ganglia calcifications, cataracts and dental abnormalities [10, 11, 12, 13, 14, 15].

In case of HPP, the main purpose of treatment is to maintain normal blood calcium levels. Medical therapy of hypocalcemia consists in the administration of calcium and vitamin D [16].

Although HPP after TT reverses spontaneously within a few months in most cases, in a few patients, it can persist for more than 1 year [4]. In this case this condition has to be considered permanent and, to avoid the subtle but potentially lethal complications of chronic hypocalcemia, long-term therapy and careful follow-up are mandatory. However, long-term calcium supplementation can also cause side effects, such as gastrointestinal reactions, myocardial infarction and urinary calculi [17].

The incidence of transient and permanent hypoparathyroidism is 6.9–46% and 0-10% respectively [2, 5, 18].

Costs to society in terms of increased postoperative stay, sick leave, medical treatments and surveillance, with periodic laboratory testing, are considerable. Moreover, permanent HPP is an important cause of medical litigation.

Currently, there are no reliable immediate postoperative biochemical parameters which allow the identification of those patients with postsurgical HPP who will develop permanent HPP [19]. In order to ensure patients the best follow-up, it would be very useful to be able to predict the risk of permanent HPP at an early stage after surgery. To date, there is still no consensus about the correlation between postoperative intact parathyroid hormone (iPTH) values and the development of this condition [20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34]. The aim of the present study was to investigate this topic. In particular, we evaluated whether iPTH concentrations on the first postoperative may be a good predictor of permanent HPP.

2 Methods

This is a retrospective study on patients who underwent thyroidectomy in our Unit of General and Endocrine Surgery (University of Cagliari) between January 2017 and February 2018.

Only patients with postsurgical HPP after TT were considered. Among these, those simultaneously submitted to lateral and/or central neck dissection were included in this study, while those who simultaneously underwent parathyroidectomy or parathyroid autotransplantation were excluded.

All operations were performed under general anaesthesia. Lateral and/or central neck dissection was performed in patients with preoperative or intraoperative suspicion of lymph node metastases. Recurrent laryngeal nerves and parathyroid glands were systematically searched and identified. Intraoperative nerve monitoring (IONM) was routinely used in order to facilitate nerve identification and to confirm its functional integrity. Haemostasis was mainly achieved by means of energy-based devices. One or two closed suction drains were placed below the strap muscles and removed when the secretion volume was less than 20 ml over 24 hours. The cervical linea alba and platysma were sutured with absorbable sutures and skin was closed by a continuous intradermal suture.

Demographic data (sex, age), information on surgical procedure (extent of surgery) and histopathological findings were recorded.

Serum calcium and iPTH levels were assayed preoperatively and on the first and second postoperative days. Postsurgical HPP was defined as iPTH < 10 pg/mL on the second postoperative day (normal range = 10-65 pg/mL). All patients with postsurgical HPP, even if asymptomatic, received treatment with calcium carbonate (1–3 g/day) and calcitriol (0.5–1.5 μg /day). In case of severe hypocalcemia, intravenous calcium gluconate was used.

According to iPTH values on the first postoperative day and on the basis of the detection threshold of the iPTH test used, patients were divided into 2 groups: those with iPTH < 6.3 pg/mL (undetectable) were included in Group A, those with iPTH ≥ 6.3 pg/mL in Group B.

Permanent HPP was defined as iPTH concentrations below the normal range for more than 12 months.

Intact parathyroid hormone was measured with ADVIA Centaur® XPT Immunoassay Systems (Siemens Healthcare Diagnostics, Inc.).

Statistical analyses were performed with MedCalc® 18.0.2. Fisher exact test was used for categorical variables and t-test for continuous variables. Sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) were calculated. P values < 0.05 were considered statistically significant.

Ethical approval: The research related to human use has been complied with all the relevant national regulations, institutional policies and in accordance the tenets of the Helsinki Declaration, and has been approved by the authors' institutional review board or equivalent committee.

Informed consent: Informed consent has been obtained from all individuals included in this study.

3 Results

A total of 75 patients were included in this study. There were 16 (21.33%) males and 59 (78.67%) females, with a mean age of 49.25 ± 16.77 years old. Sixty-six (88%) patients underwent total thyroidectomy, 4 (5.33%) total thyroidectomy with ipsilateral central neck dissection, 3 (4%) total thyroidectomy with central neck dissection

Table 1

Demographic data, information on surgical procedure and histopathological findings.

Table 2

Patients who developed permanent HPP.

and 2 (2.67%) total thyroidectomy with central and lateral neck dissection. Mean thyroid weight was 58.44 ± 61.08 g. Histopathological diagnosis was benign disease in 43 (57.33%) patients and malignancy in 32 (42.67%).

Of the 75 patients, 64 were included in Group A and 11 in Group B.

In Group A, there were 15 (23.44%) males and 49 (76.56%) females, with a mean age of 47.91 ± 16.99 years old. Fifty-six (87.50%) patients underwent total thyroidectomy, 3 (4.69%) total thyroidectomy with ipsilateral central neck dissection, 3 (4.69%) total thyroidectomy with central neck dissection and 2 (3.12%) total thyroidectomy with central and lateral neck dissection. Mean thyroid weight was 59.14 ± 63.79 g. Histopathological diagnosis was benign disease in 36 (56.25%) patients and malignancy in 28 (43.75%).

In Group B, there were 1 (9.09%) male and 10 (99.91%) females, with a mean age of 57.09 ± 13.55 years old. Ten (90.91%) patients underwent total thyroidectomy and 1 (9.09%) total thyroidectomy with ipsilateral central neck dissection. Mean thyroid weight was 54.36 ± 44.11 g. Histopathological

Table 3

Correlation between iPTH levels < 6.3 pg/mL on the first postoperative day and the development of permanent HPP.

diagnosis was benign disease in 7 (63.64%) patients and malignancy in 4 (36.36%).

Demographic data, extent of surgery and histopathological findings were comparable between the 2 groups.

Permanent HPP occurred in 14 (21.88%) patients in Group A, while none developed this complication in Group B (this difference was not statistically significant).

When iPTH levels were < 6.3 pg/mL on the first postoperative day the sensitivity for the prediction of permanent HPP was 100%, the specificity was 18.03%, the PPV was 21.88% and the NPV was 100%.

4 Discussion

Despite progress in surgical technique and even in the most experienced hands, postsurgical HPP remains a challenging problem. Permanent HPP is the most common long-term complication after TT [1, 2, 3, 4, 5, 6, 7, 8, 9].

During surgery parathyroid glands can be damaged due to various mechanisms: thermal or mechanical stress, vascular injury (interrupted blood flow or impaired venous efflux) and involuntary removal [7, 31, 35, 36, 37].

Some factors have been associated with an increased risk of developing postsurgical HPP, such as female gender, thyroid cancer, Graves’ disease, autoimmune thyroiditis and central neck dissection [1, 31, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45,].

To date, there is still no consensus about the usefulness of postoperative iPTH levels to predict permanent HPP [20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34]. We evaluated whether iPTH values on the first postoperative day may be a good predictor of this complication. In the literature, we found some similar studies.

Almquist M. et al [29] stated that iPTH levels measured on the first postoperative day are associated with the risk of permanent HPP. In their experience, of 10 patients with permanent HPP, 8 had iPTH < 6.6 pg/mL and 2 had iPTH between 6.6 and 15 pg/mL. However, among the patients with iPTH values < 6.6 pg/mL the rate of this complication was only 19.2%.

In the study of Julián M.T. et al [30], iPTH concentrations ≤ 5.8 pg/mL on postoperative day 1 had 100% sensitivity, 81.5% specificity and 30% positive predictive value for permanent HPP. Conversely, iPTH levels > 5.8 pg/mL were correlated with normal parathyroid function in the long term.

In the experience of Wang J.B. et al [31], iPTH concentrations < 7 pg/mL on postoperative day 1 had sensitivity and negative predictive value of 100% for permanent HPP, but poor specificity and positive predictive value (70.19% and 8.63% respectively).

Kim H. et al [32] stated that the safest cut-off value of iPTH on the first postoperative day for the prediction of permanent HPP is 9.65 pg/mL (70.9% sensitivity and 100% specificity). None of the patients with iPTH > 9.65 pg/mL developed this complication.

In the study of Wang W. et al [33], iPTH levels ≤ 3.14 pg/mL on postoperative day 1 had 100% sensitivity for the prediction of permanent HPP, 95% specificity, 66.67% positive predictive value and 100% negative predictive value. Therefore, these researchers stated that iPTH levels > 3.14 pg/mL are great in assessing the absence of this complication.

Calvo Espino P. et al [34] found that a cut-off value of iPTH on the first postoperative day of 5 pg/mL has 95% sensitivity, 77% specificity, 21.6% positive predictive value and 99.6% negative predictive value for the prediction of permanent HPP. Therefore, they stated that this iPTH level, because of its high negative predictive value, is a useful predictor of permanent HPP.

In our study, we included only patients with postsurgical HPP, diagnosed on the basis of iPTH concentrations on the second postoperative day. According to our experience and that of other researchers, we consider iPTH values on postoperative day 2, rather than on postoperative day 1, more accurate in assessing the true functional state of parathyroid glands after TT. Among the patients considered, iPTH levels on the first postoperative day have been analysed. When iPTH concentrations were < 6.3 pg/ mL, the sensitivity and the negative predictive value for permanent HPP were high (both 100%), but the specificity and the positive predictive value were poor, 18.03% and 21.88% respectively. It is important to underline that no patient with iPTH values ≥ 6.3 pg/mL developed this complication. As already explained above, in our study, the cut-off value was established on the basis of the detection threshold of the iPTH test used. Among the 2 groups obtained in this way, no statistically significant difference was found in terms of demographic data, extent of surgery and histopathological findings.

In light of the results obtained by our and the other studies analysed, to date, a cut-off value of iPTH on the first postoperative day accurate enough for the prediction of permanent HPP has not yet been identified. Thus, further larger and possibly multicenter studies are needed to better investigate this topic.

5 Conclusions

No patient with iPTH levels ≥ 6.3 pg/mL on the first postoperative day after TT developed permanent HPP. On the other hand, iPTH concentrations < 6.3 pg/mL have not proved to be a strong predictor of this condition (PPV, 21.88%; specificity, 18.03%). However, this cut-off value can be useful to identify patients at risk of developing this complication (sensitivity, 100%), who require a careful follow-up.

References

  • [1]

    Puzziello A, Rosato L, Innaro N, Orlando G, Avenia N, Perigli G, Calò PG, De Palma M. Hypocalcemia following thyroid surgery: incidence and risk factors. A longitudinal multicenter study comprising 2,631 patients. Endocrine. 2014;47:537-542 Google Scholar

  • [2]

    Bilezikian JP, Khan A, Potts JT Jr, Brandi ML, Clarke BL, Shoback D, Jüppner H, D’Amour P, Fox J, Rejnmark L, Mosekilde L, Rubin MR, Dempster D, Gafni R, Collins MT, Sliney J, Sanders J. Hypoparathyroidism in the adult: epidemiology, diagnosis, pathophysiology, target-organ involvement, treatment, and challenges for future research. J Bone Miner Res. 2011;26:2317-2337 PubMedCrossrefWeb of ScienceGoogle Scholar

  • [3]

    Asari R, Passler C, Kaczirek K, Scheuba C, Niederle B. Hypoparathyroidism after total thyroidectomy: a prospective study. Arch Surg. 2008;143:132-137 CrossrefPubMedWeb of ScienceGoogle Scholar

  • [4]

    Villarroya-Marquina I, Sancho J, Lorente-Poch L, Gallego-Otaegui L, Sitges-Serra A. Time to parathyroid function recovery in patients with protracted hypoparathyroidism after total thyroidectomy. Eur J Endocrinol. 2018;178:105-113 Web of ScienceGoogle Scholar

  • [5]

    Pattou F, Combemale F, Fabre S, Carnaille B, Decoulx M, Wemeau JL, Racadot A, Proye C. Hypocalcemia following thyroid surgery: incidence and prediction of outcome. World J Surg. 1998;22:718-724 CrossrefPubMedGoogle Scholar

  • [6]

    Calò PG, Pisano G, Medas F, Tatti A, Tuveri M, Nicolosi A. Risk factors in reoperative thyroid surgery for recurrent goitre: our experience. G Chir. 2012;33:335-338 PubMedGoogle Scholar

  • [7]

    Lorente-Poch L, Sancho JJ, Ruiz S, Sitges-Serra A. Importance of in situ preservation of parathyroid glands during total thyroidectomy. Br J Surg. 2015;102:359-367 CrossrefWeb of SciencePubMedGoogle Scholar

  • [8]

    Calò PG, Medas F, Conzo G, Podda F, Canu GL, Gambardella C, Pisano G, Erdas E, Nicolosi A. Intraoperative neuromonitoring in thyroid surgery: Is the two-staged thyroidectomy justified? Int J Surg. 2017;41 Suppl 1:S13-S20 CrossrefWeb of SciencePubMedGoogle Scholar

  • [9]

    Conzo G, Avenia N, Ansaldo GL, Calò P, De Palma M, Dobrinja C, Docimo G, Gambardella C, Grasso M, Lombardi CP, Pelizzo MR, Pezzolla A, Pezzullo L, Piccoli M, Rosato L, Siciliano G, Spiezia S, Tartaglia E, Tartaglia F, Testini M, Troncone G, Signoriello G. Surgical treatment of thyroid follicular neoplasms: results of a retrospective analysis of a large clinical series. Endocrine. 2017;55:530-538 CrossrefWeb of SciencePubMedGoogle Scholar

  • [10]

    Lorente-Poch L, Sancho JJ, Muñoz-Nova JL, Sánchez-Velázquez P, Sitges-Serra A. Defining the syndromes of parathyroid failure after total thyroidectomy. Gland Surg. 2015;4:82-90 Web of SciencePubMedGoogle Scholar

  • [11]

    Lorente-Poch L, Sancho JJ, Carballo L, Sitges-Serra A. Clinical profile and long-term follow-up of 32 patients with postoperative permanent hypoparathyroidism. Gland Surg. 2017;6 Suppl 1:S3-S10 CrossrefPubMedWeb of ScienceGoogle Scholar

  • [12]

    Mitchell DM, Regan S, Cooley MR, Lauter KB, Vrla MC, Becker CB, Burnett-Bowie SA, Mannstadt M. Long-term follow-up of patients with hypoparathyroidism. J Clin Endocrinol Metab. 2012;97:4507-4514 PubMedCrossrefWeb of ScienceGoogle Scholar

  • [13]

    Rastogi R, Beauchamp NJ, Ladenson PW. Calcification of the basal ganglia in chronic hypoparathyroidism. J Clin Endocrinol Metab. 2003;88:1476-1477 CrossrefPubMedGoogle Scholar

  • [14]

    Kinirons MJ, Glasgow JF. The chronology of dentinal defects related to medical findings in hypoparathyroidism. J Dent. 1985;13:346-349 CrossrefPubMedGoogle Scholar

  • [15]

    Sitges-Serra A, Ruiz S, Girvent M, Manjon H, Duenas JP, Sancho JJ. Outcome of protracted hypoparathyroidism after total thyroidectomy. Br J Surg. 2010;97:1687–1695 Web of SciencePubMedCrossrefGoogle Scholar

  • [16]

    Khan MI, Waguespack SG, Hu MI. Medical management of postsurgical hypoparathyroidism. Endocr Pract. 2011;17 Suppl 1:18-25 PubMedWeb of ScienceCrossrefGoogle Scholar

  • [17]

    Reid IR, Bristow SM, Bolland MJ. Calcium supplements: benefits and risks. J Intern Med. 2015;278:354-368 CrossrefPubMedWeb of ScienceGoogle Scholar

  • [18]

    Costanzo M, Marziani A, Condorelli F, Migliore M, Cannizzaro MA. Post-thyroidectomy hypocalcemic syndrome: predictive value of early PTH. Preliminary results. Ann Ital Chir. 2010;81:301-305 Google Scholar

  • [19]

    Chia SH, Weisman RA, Tieu D, Kelly C, Dillmann WH, Orloff LA. Prospective study of perioperative factors predicting hypocalcemia after thyroid and parathyroid surgery. Arch Otolaryngol Head Neck Surg. 2006;132:41-45 PubMedCrossrefGoogle Scholar

  • [20]

    Sitges-Serra A, Gómez J, Barczynski M, Lorente-Poch L, Iacobone M, Sancho J. A nomogram to predict the likelihood of permanent hypoparathyroidism after total thyroidectomy based on delayed serum calcium and iPTH measurements. Gland Surg. 2017;6 Suppl 1:S11-S19 PubMedWeb of ScienceCrossrefGoogle Scholar

  • [21]

    Hermann M, Ott J, Promberger R, Kober F, Karik M, Freissmuth M. Kinetics of serum parathyroid hormone during and after thyroid surgery. Br J Surg. 2008;95:1480-1487 CrossrefPubMedWeb of ScienceGoogle Scholar

  • [22]

    Lombardi CP, Raffaelli M, Princi P, Santini S, Boscherini M, De Crea C, Traini E, D’Amore AM, Carrozza C, Zuppi C, Bellantone R. Early prediction of postthyroidectomy hypocalcemia by one single iPTH measurement. Surgery. 2004;136:1236-1241 CrossrefPubMedGoogle Scholar

  • [23]

    Raffaelli M, De Crea C, Carrozza C, D’Amato G, Zuppi C, Bellantone R, Lombardi CP. Combining early postoperative parathyroid hormone and serum calcium levels allows for an efficacious selective post-thyroidectomy supplementation treatment. World J Surg. 2012;36:1307-1313 PubMedWeb of ScienceCrossrefGoogle Scholar

  • [24]

    Del Río L, Castro A, Bernáldez R, Del Palacio A, Giráldez CV, Lecumberri B, Alvarez-Escolá C, Fernández-Martínez A. Parathyroid hormone as a predictor of post-thyroidectomy hypocalcemia. Acta Otorrinolaringol Esp. 2011;62:265-273 PubMedGoogle Scholar

  • [25]

    AlQahtani A, Parsyan A, Payne R, Tabah R. Parathyroid hormone levels 1 hour after thyroidectomy: an early predictor of postoperative hypocalcemia. Can J Surg. 2014;57:237-240 PubMedWeb of ScienceCrossrefGoogle Scholar

  • [26]

    Saba A, Podda M, Messina Campanella A, Pisanu A. Early prediction of hypocalcemia following thyroid surgery. A prospective randomized clinical trial. Langenbecks Arch Surg. 2017;402:1119-1125 Google Scholar

  • [27]

    Pisanu A, Saba A, Coghe F, Uccheddu A. Early prediction of hypocalcemia following total thyroidectomy using combined intact parathyroid hormone and serum calcium measurement. Langenbecks Arch Surg. 2013;398:423-430 PubMedCrossrefWeb of ScienceGoogle Scholar

  • [28]

    Stein DJ, Noordzij JP, Kepchar J, McLeod IK, Brietzke S, Calò PG. Use of Parathyroid Hormone Assay after Thyroidectomy: A Survey of US and European Surgeons. Clin Med Insights Endocrinol Diabetes. 2013;6:39-45 PubMedGoogle Scholar

  • [29]

    Almquist M, Hallgrimsson P, Nordenström E, Bergenfelz A. Prediction of permanent hypoparathyroidism after total thyroidectomy. World J Surg. 2014;38:2613-2620 CrossrefWeb of SciencePubMedGoogle Scholar

  • [30]

    Julián MT, Balibrea JM, Granada ML, Moreno P, Alastrué A, Puig-Domingo M, Lucas A. Intact parathyroid hormone measurement at 24 hours after thyroid surgery as predictor of parathyroid function at long term. Am J Surg. 2013;206:783-789 Web of ScienceCrossrefPubMedGoogle Scholar

  • [31]

    Wang JB, Sun HL, Song CY, Gao L. Association between decreased serum parathyroid hormone after total thyroidectomy and persistent hypoparathyroidism. Med Sci Monit. 2015;21:1223-1231 PubMedCrossrefGoogle Scholar

  • [32]

    Kim H, Yu HW, Bae IE, Yi JW, Lee JH, Kim SJ, Chai YJ, Choi JY, Lee KE. Prediction of Transient and Permanent Hypoparathyroidism after Total Thyroidectomy Using the Postoperative Serum Parathyroid Hormone Test: When Is the Best Time to Check? J Endocr Surg. 2017;17:104-113 CrossrefGoogle Scholar

  • [33]

    Wang W, Xia F, Meng C, Zhang Z, Bai N, Li X. Prediction of permanent hypoparathyroidism by parathyroid hormone and serum calcium 24 h after thyroidectomy. Am J Otolaryngol. 2018;39:746-750 PubMedCrossrefWeb of ScienceGoogle Scholar

  • [34]

    Calvo Espino P, Rivera Bautista JÁ, Artés Caselles M, Serrano González J, García Pavía A, García-Oria MJ, Caravaca-Fontán F, Lucena de la Poza JL, Sánchez Turrión V. Serum levels of intact parathyroid hormone on the first day after total thyroidectomy as predictor of permanent hypoparathyroidism. Endocrinol Diabetes Nutr. 2018 [Epub ahead of print] PubMedWeb of Science

  • [35]

    Qasaimeh GR, Al Nemri S, Al Omari AK. Incidental extirpation of the parathyroid glands at thyroid surgery: risk factors and post-operative hypocalcemia. Eur Arch Otorhinolaryngol. 2011;268:1047-1051 CrossrefPubMedGoogle Scholar

  • [36]

    Spiliotis J, Vaxevanidou A, Sergouniotis F, Tsiveriotis K, Datsis A, Rogdakis A, Kekelos S. Risk factors and consequences of incidental parathyroidectomy during thyroidectomy. Am Surg. 2010;76:436–441 PubMedGoogle Scholar

  • [37]

    Sitges-Serra A, Gallego-Otaegui L, Suárez S, Lorente-Poch L, Munné A, Sancho JJ. Inadvertent parathyroidectomy during total thyroidectomy and central neck dissection for papillary thyroid carcinoma. Surgery. 2017;161:712-719 CrossrefPubMedWeb of ScienceGoogle Scholar

  • [38]

    Medas F, Erdas E, Gordini L, Conzo G, Gambardella C, Canu GL, Pisano G, Nicolosi A, Calò PG. Risk of malignancy in thyroid nodules classified as TIR-3A: What therapy? Int J Surg. 2017;41 Suppl 1:S60-S64 CrossrefWeb of SciencePubMedGoogle Scholar

  • [39]

    Docimo G, Ruggiero R, Casalino G, Del Genio G, Docimo L, Tolone S. Risk factors for postoperative hypocalcemia. Updates Surg. 2017;69:255-260 CrossrefWeb of SciencePubMedGoogle Scholar

  • [40]

    Roh JL, Kim JM, Park CI. Central lymph node metastasis of unilateral papillary thyroid carcinoma: patterns and factors predictive of nodal metastasis, morbidity, and recurrence. Ann Surg Oncol. 2011;18:2245–2250 Web of SciencePubMedCrossrefGoogle Scholar

  • [41]

    Hallgrimsson P, Nordenstrom E, Bergenfelz A, Almquist M. Hypocalcaemia after total thyroidectomy for Graves’ disease and for benign atoxic multinodular goitre. Langenbecks Arch Surg. 2012;397:1133-1137 CrossrefPubMedWeb of ScienceGoogle Scholar

  • [42]

    Medas F, Erdas E, Canu GL, Longheu A, Pisano G, Tuveri M, Calò PG. Does hyperthyroidism worsen prognosis of thyroid carcinoma? A retrospective analysis on 2820 consecutive thyroidectomies. J Otolaryngol Head Neck Surg. 2018;47:6 CrossrefWeb of SciencePubMedGoogle Scholar

  • [43]

    Calò PG, Conzo G, Raffaelli M, Medas F, Gambardella C, De Crea C, Gordini L, Patrone R, Sessa L, Erdas E, Tartaglia E, Lombardi CP. Total thyroidectomy alone versus ipsilateral versus bilateral prophylactic central neck dissection in clinically node-negative differentiated thyroid carcinoma. A retrospective multicenter study. Eur J Surg Oncol. 2017;43:126-132 CrossrefPubMedGoogle Scholar

  • [44]

    Conzo G, Tartaglia E, Avenia N, Calò PG, de Bellis A, Esposito K, Gambardella C, Iorio S, Pasquali D, Santini L, Sinisi MA, Sinisi AA, Testini M, Polistena A, Bellastella G. Role of prophylactic central compartment lymph node dissection in clinically N0 differentiated thyroid cancer patients: analysis of risk factors and review of modern trends. World J Surg Oncol. 2016;14:149 CrossrefPubMedWeb of ScienceGoogle Scholar

  • [45]

    Pesce CE, Shiue Z, Tsai HL, Umbricht CB, Tufano RP, Dackiw AP, Kowalski J, Zeiger MA. Postoperative hypocalcemia after thyroidectomy for Graves’ disease. Thyroid. 2010;20:1279-1283 CrossrefPubMedWeb of ScienceGoogle Scholar

About the article

Tel. +393408320129


Received: 2019-02-26

Accepted: 2019-04-24

Published Online: 2019-06-07


Conflict of interest: Authors state no conflict of interest.


Citation Information: Open Medicine, Volume 14, Issue 1, Pages 437–442, ISSN (Online) 2391-5463, DOI: https://doi.org/10.1515/med-2019-0047.

Export Citation

© 2019 Gian Luigi Canu et al., published by De Gruyter. This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License. BY-NC-ND 4.0

Comments (0)

Please log in or register to comment.
Log in